BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 10, 2008
View Archived Issues
Novel immunosuppressants reported in Daiichi Sankyo patent
Read More
Novel anticancer agents revealed in patent literature
Read More
Study examines reduced calcineurin inhibitor doses in renal transplant patients
Read More
Studies examine activity of LY-686017 in alcoholism, social anxiety and IBS
Read More
New treatment options for inflammatory and autoimmune diseases claimed in recent patents
Read More
Update on development of hepatitis C protease inhibitor telaprevir
Read More
Alseres completes enrollment in phase I/IIa clinical trial of Cethrin and plans phase IIb trial
Read More
NicOx and Pfizer extend ophthalmology collaboration agreement
Read More
Ortho-McNeil puts APD-668 for type 2 diabetes on hold, advances other GDIR agonist
Read More
Baxter initiates preclinical programs for recombinant factor IX proteins for hemophilia B
Read More
Tacere signs collaboration and license agreement with Pfizer for TT-033 for HCV
Read More
Phase II study of Hemospan for chronic critical limb ischemia begins
Read More
Evotec' EVT-302 for smoking cessation well tolerated in phase I study
Read More
FDA approves Medarex's IND application for anti-CD70 antibody MDX-1411
Read More
ZymoGenetics initiates phase II trial of IL-21 with Nexavar for renal cell cancer
Read More
Incyte reports positive clinical results from studies of INCB-18424 and INCB-13739
Read More
COL4A1, candidate gene for newly described systemic basement-membrane syndrome
Read More
Phase III study of oxybutynin topical gel for OAB meets primary and secondary endpoints
Read More
Sirtris reports positive results from phase Ib study of SRT-501 for type 2 diabetes
Read More
Neurogen reports results of follow-up component of phase I study of NGD-4715 for obesity
Read More
Ambien CR tablets CIV improve chronic insomnia in GAD patients
Read More
Therapeutic potential of GLS1 inhibition in schizophrenia
Read More